Skip to content

Adaptations to Pharmacy during COVID and Current Positions

In Oct 2020, BOPA produced the Changing Services, Changing Oncology Pharmacy COVID-19 Position Statement. The aim of the document was to outline both the clinical and operational responses implemented by BOPA members during the initial phase of COVID-19. The document also highlighted some of the future steps oncology pharmacy services and the wider oncology service could have taken at that point in planning for the future phases of the COVID-19 pandemic.
 
Now with the benefit of hindsight and in the spirit of reflective practice, we are asking BOPA members to complete this survey which discusses those changes made and whether these continue into current practice. The survey responses will form part of a updated Position Statement and associated journal article which will enable all BOPA members to benefit from the collective learning of the membership throughout and COVID pandemic, to the present and into the future to meet the challenges we currently and will continue to face within oncology pharmacy
1.Trust/Hospital Name (optional)
2.Did your hospital/trust develop NEW processes to implement COVID associated SACT guidance
3.If YES , does this NEW process continue to date
4.Did your hospital/trust implement treatment adjustments and /or treatment switches in response to COVID (e.g 3 monthly denosumb, reduction in use of chemotherapy)?
5.If YES, did these implemented treatment adjustments and/or treatment switches continue to date ?
6.Did your hospital/trust implement supportive treatment (eg. Increased GCSF use, antiemetic switches) changes in response to COVID?
7.If YES , did these implemented treatment adjustments or switches continue to date ?
8.Were the pharmacy workforce utilized to provide contingency for SACT workforce (i.e increased NMP sessions, pharmacy patient counselling etc)?
9. If YES, did these implemented treatment adjustments or switches continue to date ?
10.Did your trust/hospital increase use of homecare providers in response to COVID?
11.If YES, does the increase in homecare providers continue to date ?
12.Did your trust/hospital implement alternative delivery models excluding homecare in response to COVID? (e.g use of couriers or drive through collections)
13.If YES, does the increase in homecare providers continue to date ?
14.Did your trust/hospital increase self /carer administration in response to COVID? (e.g self administration of Denosumab etc)?
15.If YES, does the increased self or carer administration continue to date ?
16.Did your trust/hospital use “COVID light” sites to deliver SACT in response to COVID? (A COVID light site is one where COVID + patients are not actively admitted and where restrictions to workforce and patients minimise potential for COVID transmission)
17.If YES, does the use of COVID light sites continue to date ?
18.Did your trust/hospital increase use of virtual consultations in response to COVID?
19.If YES, does the use of virtual consultations continue to date ?
20.Did your trust/hospital increase home working for pharmacy staff in response to COVID?
21.If YES , does the home working for pharmacy staff continue to date ?
22.Did your trust/hospital hold cancer trial activity in response to COVID? (recruitment and/or exiting trial patient work)
23.If YES , has these changes to clinical trial work continue to date ?
24.Other relevant comments related to COVID changes and current position
Current Progress,
0 of 24 answered